SARS-CoV-2 antibodies seroprevalence in dogs from France using ELISA and an automated western blotting assay

Younes Laidoudi (1) , Youssouf Sereme (1) , Hacène Medkour (1) , Stéphanie Watier-Grillot (2) , Pierre Scandola (2) , Jacques Ginesta (2) , Virginie Andréo (2) , Claire Labarde (2) , Loïc Comtet (3) , Philippe Pourquier (3) , Didier Raoult (1) , Jean-Lou Marié (2) , Bernard Davoust (1, 4)

1 MEPHI - Microbes évolution phylogénie et infections
2 CESPA - Centre d'épidémiologie et de santé publique des armées [Marseille]
3 IDvet [Grabels]
4 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

Younes Laidoudi, Youssouf Sereme, Hacène Medkour, Stéphanie Watier-Grillot, Pierre Scandola, et al.. SARS-CoV-2 antibodies seroprevalence in dogs from France using ELISA and an automated western blotting assay. One Health, 2021, 13, pp.100293. ⟨10.1016/j.onehlt.2021.100293⟩. ⟨hal-03437060⟩